Total Payments
$3,282
2024 Payments
$472.37
Companies
19
Transactions
158
Medicare Patients
6,192
Medicare Billing
$282,330
Payment Breakdown by Category
Food & Beverage$3,282 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,282 | 158 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $706.80 | 42 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $540.29 | 27 | $0 (2024) |
| PFIZER INC. | $415.74 | 26 | $0 (2024) |
| Abbott Laboratories | $261.58 | 8 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $190.61 | 8 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $187.11 | 9 | $0 (2024) |
| Edwards Lifesciences Corporation | $150.00 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $135.60 | 8 | $0 (2024) |
| Medtronic, Inc. | $118.77 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $108.45 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $472.37 | 16 | Edwards Lifesciences Corporation ($150.00) |
| 2023 | $252.65 | 13 | AstraZeneca Pharmaceuticals LP ($100.01) |
| 2022 | $358.32 | 14 | Medtronic, Inc. ($118.77) |
| 2021 | $46.72 | 2 | PFIZER INC. ($24.29) |
| 2020 | $249.38 | 13 | Novartis Pharmaceuticals Corporation ($63.25) |
| 2019 | $338.01 | 18 | AstraZeneca Pharmaceuticals LP ($83.88) |
| 2018 | $913.41 | 45 | PFIZER INC. ($202.24) |
| 2017 | $651.48 | 37 | Novartis Pharmaceuticals Corporation ($260.55) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/22/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Not Applicable | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: RESPIRATORY | ||||||
| 05/29/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.71 | General |
| Category: Cardiovascular | ||||||
| 01/09/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 12/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/19/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,374 | 1,981 | $220,785 | $63,003 |
| 2022 | 9 | 1,540 | 2,198 | $235,540 | $72,171 |
| 2021 | 10 | 1,617 | 2,231 | $247,630 | $84,042 |
| 2020 | 6 | 1,661 | 2,418 | $240,544 | $63,114 |
Total Patients
6,192
Total Services
8,828
Medicare Billing
$282,330
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 423 | $125,640 | $34,254 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 182 | $37,380 | $9,928 | 26.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 799 | 1,022 | $20,440 | $7,443 | 36.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $12,250 | $3,678 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $11,235 | $3,379 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 19 | $8,160 | $2,509 | 30.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 206 | 284 | $5,680 | $1,813 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 209 | 450 | $126,450 | $37,461 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 110 | 202 | $38,700 | $11,622 | 30.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 899 | 1,122 | $22,440 | $8,566 | 38.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $17,280 | $5,176 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $8,490 | $2,470 | 29.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 32 | $6,400 | $2,185 | 34.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 210 | 299 | $5,980 | $2,017 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 15 | $6,300 | $1,985 | 31.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 14 | $2,730 | $442.86 | 16.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 11 | 11 | $770.00 | $246.76 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 225 | 508 | $129,540 | $45,129 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 106 | 163 | $28,525 | $9,996 | 35.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 871 | 1,039 | $30,131 | $7,716 | 25.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 44 | 44 | $21,384 | $7,642 | 35.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 36 | 39 | $13,299 | $4,074 | 30.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 49 | 62 | $6,200 | $3,691 | 59.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 213 | 288 | $8,352 | $2,004 | 24.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 19 | $2,850 | $1,641 | 57.6% |
About Dr. Chaim Levine, MD
Dr. Chaim Levine, MD is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962442863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chaim Levine, MD has received a total of $3,282 in payments from pharmaceutical and medical device companies, with $472.37 received in 2024. These payments were reported across 158 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,282).
As a Medicare-enrolled provider, Levine has provided services to 6,192 Medicare beneficiaries, totaling 8,828 services with total Medicare billing of $282,330. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Internal Medicine
- Location Brooklyn, NY
- Active Since 06/08/2006
- Last Updated 10/03/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962442863
Products in Payments
- ENTRESTO (Drug) $659.82
- ELIQUIS (Drug) $388.88
- FARXIGA (Drug) $373.50
- HeartMate 3 Left Ventricular Dev (Device) $206.09
- XARELTO (Drug) $190.61
- MULTAQ (Drug) $187.11
- BRILINTA (Drug) $166.79
- CHANTIX (Drug) $139.75
- AVALUS (Device) $118.77
- VERQUVO (Drug) $108.45
- JARDIANCE (Drug) $68.13
- LifeVest (Device) $62.29
- Vascepa (Drug) $58.72
- PRALUENT (Biological) $50.66
- LEQVIO (Drug) $46.98
- WATCHMAN DEVICE (Device) $35.84
- ADVAIR (Drug) $35.57
- WATCHMAN FLX (Device) $33.05
- PRALUENT ALIROCUMAB INJECTION (Biological) $31.93
- Circulatory Support (Device) $23.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799